Sofosbuvir–velpatasvir and sofosbuvir–velpatasvir–voxilaprevir: novel treatment options for naïve and previously treated hepatitis C infection

Detalles Bibliográficos
Autor principal: Shin, Hyun Phil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association of Internal Medicine 2023
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10338249/
https://www.ncbi.nlm.nih.gov/pubmed/37424499
http://dx.doi.org/10.3904/kjim.2023.248

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10338249/
https://www.ncbi.nlm.nih.gov/pubmed/37424499
http://dx.doi.org/10.3904/kjim.2023.248

Ejemplares similares